{{unreferenced|date=January 2015}}
{{Drugbox
| verifiedrevid = 448141571
| IUPAC_name = (''RS'')-4-[3-(tert-butylamino)-2-hydroxypropoxy]-2-methylisoquinolin-1-one
| image = Tilisolol.svg
| chirality = [[Racemic mixture]]
| drug_name = 
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|tilisolol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 85136-71-6
| CAS_supplemental = <br/>{{CAS|62774-96-3}} ([[hydrochloride]])
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 5474
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = QUF41MF56G
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08598
| ChemSpiderID      = 5275

<!--Chemical data-->
| C=17 | H=24 | N=2 | O=3 
| molecular_weight = 304.38 g/mol
| smiles = CC(C)(C)NCC(COC1=CN(C(=O)C2=CC=CC=C21)C)O
| StdInChI          = 1S/C17H24N2O3/c1-17(2,3)18-9-12(20)11-22-15-10-19(4)16(21)14-8-6-5-7-13(14)15/h5-8,10,12,18,20H,9,11H2,1-4H3
| StdInChIKey       = TWVUMMQUXMYOOH-UHFFFAOYSA-N
}}
'''Tilisolol''' ([[International Nonproprietary Name|INN]], trade name '''Selecal''') is a [[beta blocker]].

{{Beta blockers}}

[[Category:Beta blockers]]
[[Category:Lactams]]
[[Category:Isoquinolines]]
[[Category:Phenol ethers]]
[[Category:Alcohols]]


{{antihypertensive-stub}}